EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma

Annals of Surgical Oncology - United States
doi 10.1245/s10434-017-6180-0
Full Text
Abstract

Available in full text

Categories
OncologySurgery
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reply to “EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma”

Annals of Surgical Oncology
OncologySurgery
2017English

PUB047 Efficacy of EGFR-TKI for Lung Adenosquamous Cell Carcinoma Harboring EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Survival Analysis for Lung Adenosquamous Carcinoma Patients With Brain Metastasis

Journal of Cancer
Oncology
2018English

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

Oncology Letters
Cancer ResearchOncology
2014English

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal
2020English

EGFR Mutation Status in Tunisian Non-Small-Cell Lung Cancer Patients Evaluated by Mutation-Specific Immunohistochemistry

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

P2.09-12 EGFR Mutation Status in Squamous Cell Carcinoma or Non-Small Cell Carcinoma Favor Squamous Cell Carcinoma Diagnosed From Small Lung Biopsies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation

Cancers
Cancer ResearchOncology
2019English

Gefitinib for a Poor Performance Status Patient With Squamous Cell Carcinoma of the Lung Harboring EGFR Mutation

Internal Medicine
Internal MedicineMedicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy